Chiyoe Kitagawa
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Case Report: Adult-onset diffuse hepatic hemangiomatosis with rapid progression: an autopsy case with diagnostic difficulty.
Journal: Frontiers in medicine
Published: May 25, 2026
Clinical Outcomes in Advanced Gastric Cancer Among Patients Aged ≥80 Years Treated With Chemotherapy.
Journal: Anticancer research
Published: March 21, 2026
Real-world platinum selection in immune checkpoint inhibitor-based therapy for recurrent or metastatic head and neck cancer: an exploratory multi-institutional retrospective study.
Journal: Scientific reports
Published: October 30, 2025
Olanzapine for nausea and vomiting in people with breast cancer treated with trastuzumab deruxtecan: plain language summary of the ERICA study.
Journal: Future oncology (London, England)
Published: October 24, 2025
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 03, 2025
Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial.
Journal: JAMA network open
Published: August 15, 2025
Efficacy of Combined Dabrafenib and Trametinib Therapy in BRAFV600E Mutant Intrahepatic Cholangiocarcinoma with a Neurofibromatosis Type 2 Mutation.
Journal: Internal medicine (Tokyo, Japan)
Published: April 29, 2025
A Case of Undifferentiated Sarcoma of the Liver in an Adult Treated with Right Hepatectomy Followed by Adjuvant Chemotherapy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 27, 2024
A randomized, double-blind, placebo-controlled phase II study of olanzapine-based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 29, 2024
A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer.
Journal: BMC cancer
Published: June 24, 2024
Last Updated: 09/26/2026